Bank of Baroda Fund Raise of ₹6,000 Cr

Bank of Baroda Other Announcement

Bank of Baroda intimated that its RTA, KFin Technologies, is shifting its corporate office to a new Kokapet, Hyderabad address effective 1 December 2026. The registered office remains unchanged.

Bank of Baroda Earnings Call Transcript: Key Takeaways

Q2 FY27 PAT ₹6,532 Cr (+38.8% YoY) includes ₹349 Cr NSE-stake gain and is cushioned by ₹1,300 Cr NPA and ₹300 Cr contingency provisions. Growth is flattered by FCNRB inflows.

Bank of Baroda Annual General Meeting

Bank of Baroda will hold an EGM on 21 December 2026 to elect one shareholder director. The cut-off date for shareholders is 20 November 2026.

Bank of Baroda Investor Presentation: Key Takeaways

Q2FY27 PAT ₹6,532 cr (+35.8% YoY) and operating profit ₹11,430 cr (+50.9%), lifted by ₹4,093 cr treasury income. Global advances +18.3%, deposits +16.4%.

Bank of Baroda Q2 FY27 Results: Net Profit ₹6,737 Cr, Up 31.2% YoY

Bank of Baroda reported revenue from operations of ₹37,021 Cr (+11.1% YoY) and net profit of ₹6,737 Cr (+31.2% YoY) for Q2 FY27.

Key figure

Net profit ₹6,737 Cr · +31.2% YoY

Bank of Baroda Legal & Regulatory

Bank of Baroda clarified media-reported interim applications filed by Dr. BR Shetty in the Bombay High Court. The bank says it has not been served and calls the allegations untested.

AGI Infra Fund Raise

AGI Infra shareholders approved a special resolution to raise funds via QIP through postal ballot. Votes in favour were 100% of votes polled; no amount stated.

Pajson Agro India Fund Raise of ₹354.5 Cr

Pajson Agro's board approved a Rs.354.52 Crore preferential issue of 1,20,58,397 equity shares at Rs.294 each. Shareholder approval is sought at a meeting on 04-12-2026.

Value

₹354.5 Cr

Evonile Pharma Fund Raise of ₹900 Cr

Evonile Pharma's board approved a partly paid rights issue of up to Rs 900 Crore. A committee will set the issue price, record date and entitlement.

Value

₹900.0 Cr

Lloyds Metals & Energy Fund Raise

Lloyds Metals and Energy's board approved a fund raise, with the mode of financing yet to be decided. Investors should watch for the eventual issuance structure and size.

Shlokka Dyes Fund Raise of ₹24.5 Cr

Shlokka Dyes board approved a ₹24.50 Crore preferential issue of equity shares and warrants. Shareholder approval is pending at a November 28, 2026 meeting.

Value

₹24.50 Cr

Crescentis Capital Fund Raise of ₹79.62 Cr

Crescentis Capital's board approved the Letter of Offer for a rights issue of 1,02,08,129 shares at Rs.78 each. The issue aggregates to Rs.7,962.34 lakhs, or about Rs.79.62 Crore, assuming full subscription.

Value

₹79.62 Cr

Execution

Issue opening November 16, 2026; closing November 27, 2026; listing on or about December 3, 2026